Linezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk Factors
- PMID: 33614576
- PMCID: PMC7893085
- DOI: 10.3389/fpubh.2021.570650
Linezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk Factors
Abstract
Background:Enterococcus faecalis has been commonly considered as one of the major pathogens of the urinary tract infection (UTI) in human host worldwide, whereas the molecular characteristics of E. faecalis clinical isolates from the patients with UTI in China remains seldomly reported. This study aimed to investigate the resistance mechanism, molecular characteristics and risk factors of E. faecalis clinical isolates from patients with UTI in China. Methods: A total of 115 non-duplicated E. faecalis clinical isolates from patients with UTI were retrospectively collected in a tertiary hospital in China and their clinical data was further analyzed. The linezolid and tedizolid susceptibility were determined by agar dilution. The resistance genes, including erm(A), erm(B), erm(C), tet(M), optrA, cfr, cfr(B), poxtA, and MLST-based housekeeping genes were investigated by PCR. Results: In 115 non-duplicated E. faecalis clinical isolates from the patients with UTI in this hospital setting, the frequency of linezolid or tedizolid-resistant/intermediate isolates were 22.61 and 13.04%, respectively, and the frequency of linezolid-resistant/intermediate E. faecalis clinical isolates carrying with erm(A) were 86%. Among the five linezolid-resistant E. faecalis strains found in this study, three optrA-positive isolates and the other two linezolid-resistant strains were G2576U genetic mutations in the V domain of the 23S rRNA genes. The ST clonality analysis indicated that 31.42% (11/35) of ST16 E. faecalis UTI isolates were not susceptible to linezolid. Moreover, the univariable analysis indicated that the high risk factors of linezolid-resistant/intermediate E. faecalis infections involved the indwelling catheter, trachea cannula catheter and the carriage of erm(A) or optrA. Furthermore, the indwelling catheter and trachea cannula catheter were demonstrated as the independent predictors of linezolid-resistant/intermediate E. faecalis strains in patients with UTI by multivariable analysis. Conclusion: Linezolid-resistant/intermediate E. faecalis associated with urinary tract infections of patients in this hospital setting from China might be explained by the high carriage frequency of optrA genes and moreover, indwelling catheter and trachea cannula should be considered as the independent predictors of linezolid-resistant/intermediate E. faecalis infections. The transmission mechanism of linezolid-resistant/intermediate E. faecalis in this hospital setting should be further studied.
Keywords: Enterococcus faecalis; linezolid resistance; resistance genes; urinary tract infection; virulence factor.
Copyright © 2021 Ma, Zhang, Bai, Lin, Xu, Chen, Sun, Zheng, Deng and Yu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China.J Glob Antimicrob Resist. 2019 Jun;17:180-186. doi: 10.1016/j.jgar.2019.01.001. Epub 2019 Jan 11. J Glob Antimicrob Resist. 2019. PMID: 30641287
-
Antimicrobial resistance, virulence gene profiles, and molecular epidemiology of enterococcal isolates from patients with urinary tract infections in Shanghai, China.Microbiol Spectr. 2025 Jan 7;13(1):e0121724. doi: 10.1128/spectrum.01217-24. Epub 2024 Nov 29. Microbiol Spectr. 2025. PMID: 39612477 Free PMC article.
-
Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes.Int J Antimicrob Agents. 2020 Jun;55(6):105977. doi: 10.1016/j.ijantimicag.2020.105977. Epub 2020 Apr 22. Int J Antimicrob Agents. 2020. PMID: 32330583
-
The emerging problem of linezolid-resistant enterococci.J Glob Antimicrob Resist. 2018 Jun;13:11-19. doi: 10.1016/j.jgar.2017.10.018. Epub 2017 Oct 31. J Glob Antimicrob Resist. 2018. PMID: 29101082
-
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.Drug Resist Updat. 2014 Apr;17(1-2):1-12. doi: 10.1016/j.drup.2014.04.002. Epub 2014 Apr 6. Drug Resist Updat. 2014. PMID: 24880801 Review.
Cited by
-
Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China.BMC Med Genomics. 2024 Jul 1;17(1):174. doi: 10.1186/s12920-024-01948-x. BMC Med Genomics. 2024. PMID: 38951840 Free PMC article.
-
Prevalence and Associated Factors of optrA-Positive-Enterococcus faecalis in Different Reservoirs around Farms in Vietnam.Antibiotics (Basel). 2023 May 24;12(6):954. doi: 10.3390/antibiotics12060954. Antibiotics (Basel). 2023. PMID: 37370273 Free PMC article.
-
ESKAPE in China: epidemiology and characteristics of antibiotic resistance.Emerg Microbes Infect. 2024 Dec;13(1):2317915. doi: 10.1080/22221751.2024.2317915. Epub 2024 Feb 23. Emerg Microbes Infect. 2024. PMID: 38356197 Free PMC article. Review.
-
Genomics to understand the global landscape of linezolid resistance in Enterococcus faecium and Enterococcus faecalis.Microb Genom. 2025 Jun;11(6):001432. doi: 10.1099/mgen.0.001432. Microb Genom. 2025. PMID: 40531180 Free PMC article.
-
Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci.Pharmacy (Basel). 2021 Oct 26;9(4):175. doi: 10.3390/pharmacy9040175. Pharmacy (Basel). 2021. PMID: 34842791 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical